Vicus Capital’s Clorox CLX Stock Holding History

Vicus Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,503	Closed	-$205K	–	241
2024 Q2	$205K	Buy	+1,503	New	+$209K	0.02%	265
2022 Q2	–	Sell	-2,813	Closed	-$391K	–	222
2022 Q1	$391K	Buy	+2,813	New	+$431K	0.04%	168

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vicus Capital's CLX Position: Q3 2024 in Review

Vicus Capital sold out of Clorox (CLX) in Q3 2024, closing a stake of 1,503 shares — an estimated $205K sold.

Vicus Capital first reported a position in CLX in Q1 2022 and held it in 2 quarters. The position peaked at $391K in Q1 2022. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

Vicus Capital reported no remaining Clorox position as of Q3 2024 after selling out during the quarter.
Vicus Capital sold 1,503 Clorox shares in Q3 2024, an estimated $205K.
Vicus Capital first reported a position in Clorox in Q1 2022 and held it in 2 quarters.
Vicus Capital's Clorox position peaked at $391K in Q1 2022.
1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Vicus Capital's 13F filing for Q3 2024, filed 21 Oct 2024.